These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

912 related items for PubMed ID: 19464535

  • 1. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V, Klap JM, Seiberling MK, Herzog C, Hartmann K, Kürsteiner O, Kompier R, Grimaldi R, Goudsmit J.
    Vaccine; 2009 Jun 02; 27(27):3561-7. PubMed ID: 19464535
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y.
    Vaccine; 2009 Jan 14; 27(3):454-9. PubMed ID: 19022318
    [Abstract] [Full Text] [Related]

  • 3. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 4. Dose sparing with intradermal injection of influenza vaccine.
    Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM.
    N Engl J Med; 2004 Nov 25; 351(22):2295-301. PubMed ID: 15525714
    [Abstract] [Full Text] [Related]

  • 5. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, Weber F, Saville M.
    J Infect Dis; 2008 Sep 01; 198(5):650-8. PubMed ID: 18652550
    [Abstract] [Full Text] [Related]

  • 6. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.
    Pediatrics; 2006 Sep 01; 118(3):e579-85. PubMed ID: 16950949
    [Abstract] [Full Text] [Related]

  • 7. Clinical experience with inactivated, virosomal influenza vaccine.
    de Bruijn IA, Nauta J, Cramer WC, Gerez L, Palache AM.
    Vaccine; 2005 Jul 08; 23 Suppl 1():S39-49. PubMed ID: 16005120
    [Abstract] [Full Text] [Related]

  • 8. Virosomal hepatitis a vaccine: comparing intradermal and subcutaneous with intramuscular administration.
    Frösner G, Steffen R, Herzog C.
    J Travel Med; 2009 Jul 08; 16(6):413-9. PubMed ID: 19930383
    [Abstract] [Full Text] [Related]

  • 9. Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly.
    de Bruijn I, Meyer I, Gerez L, Nauta J, Giezeman K, Palache B.
    Vaccine; 2007 Dec 21; 26(1):119-27. PubMed ID: 18063446
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
    Wu J, Fang HH, Chen JT, Zhou JC, Feng ZJ, Li CG, Qiu YZ, Liu Y, Lu M, Liu LY, Dong SS, Gao Q, Zhang XM, Wang N, Yin WD, Dong XP.
    Clin Infect Dis; 2009 Apr 15; 48(8):1087-95. PubMed ID: 19281330
    [Abstract] [Full Text] [Related]

  • 11. Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine.
    Cooper CL, Davis HL, Morris ML, Efler SM, Krieg AM, Li Y, Laframboise C, Al Adhami MJ, Khaliq Y, Seguin I, Cameron DW.
    Vaccine; 2004 Aug 13; 22(23-24):3136-43. PubMed ID: 15297066
    [Abstract] [Full Text] [Related]

  • 12. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
    Sugimura T, Ito Y, Tananari Y, Ozaki Y, Maeno Y, Yamaoka T, Kudo Y.
    Vaccine; 2008 May 23; 26(22):2700-5. PubMed ID: 18436353
    [Abstract] [Full Text] [Related]

  • 13. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 23; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults.
    Chi RC, Rock MT, Neuzil KM.
    Clin Infect Dis; 2010 May 15; 50(10):1331-8. PubMed ID: 20377407
    [Abstract] [Full Text] [Related]

  • 15. [Study on the safety and immunogenicity of MF59-adjuvanted influenza subunit vaccine in Chinese elderly].
    Li RC, Fang HH, Li YP, Liu YP, Nong Y, Huang GB.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun 15; 29(6):548-51. PubMed ID: 19040034
    [Abstract] [Full Text] [Related]

  • 16. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 15; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 17. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
    Atmar RL, Keitel WA, Patel SM, Katz JM, She D, El Sahly H, Pompey J, Cate TR, Couch RB.
    Clin Infect Dis; 2006 Nov 01; 43(9):1135-42. PubMed ID: 17029131
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.
    Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM.
    Vaccine; 2010 Feb 17; 28(7):1740-5. PubMed ID: 20034605
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children.
    Chiu SS, Peiris JS, Chan KH, Wong WH, Lau YL.
    Pediatrics; 2007 Jun 17; 119(6):1076-82. PubMed ID: 17545373
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N, Engelmann H, Kuenzel W, Neumeier E, Saenger R.
    Virus Res; 2004 Jul 17; 103(1-2):163-71. PubMed ID: 15163505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.